Jacquemoud G, Chamay A
Clinique d'orthopédic, Hôpital Cantonal universitaire, Geneve (Suisse).
Ann Chir Main. 1982;1(1):57-64. doi: 10.1016/s0753-9053(82)80044-6.
25 cases of algodystrophy of the hand have been treated by regional intravenous guanethidine block. Pain relief was noticed in over 2/3 of the algodystrophies in stages 1 and 2, and the patients could carry on their rehabilitation. The treatment is immediately effective easy to use, without side effects and inexpensive. Unfortunately, it is not effective on the third stage of the disease. Hannington-Kiff has reported that the treatment could also be used neuro-algodystrophy of lower limbs. The authors briefly review here the pathogenesis and the clinical findings in neuro-algodystrophy.
25例手部营养障碍性骨萎缩患者接受了区域静脉注射胍乙啶阻滞治疗。在1期和2期的营养障碍性骨萎缩患者中，超过2/3的患者疼痛得到缓解，患者能够继续进行康复治疗。该治疗起效迅速、易于操作、无副作用且费用低廉。不幸的是，它对疾病的第三阶段无效。汉宁顿 - 基夫报告称，该治疗也可用于下肢神经源性营养障碍性骨萎缩。作者在此简要回顾神经源性营养障碍性骨萎缩的发病机制和临床 findings 。 （注：这里“findings”直译为“发现”，结合语境意译为“表现”更合适，但按要求未做调整）
